Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is POMALIDOMIDE, with a corresponding US DMF Number 29451.
Remarkably, this DMF maintains an Active status since its submission on June 30, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 25, 2015, and payment made on July 07, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II